NCT03905356
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be scheduled to receive radiation therapy at Penn State Cancer Institute
Exclusions: Patients who receive radiation therapy at a location other than Penn State Cancer Institute
https://ClinicalTrials.gov/show/NCT03905356